Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

13.2K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
13.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antigen-specific immunotherapy with a CD4<sup>+</sup> T cell neoepitope restrains CD8<sup>+</sup> T cell differentiation in murine pancreatic islet grafts.

Nature communications·2026
Same author

Characterization of the Cellular Immune Response to Group B Streptococcal Vaginal Colonization.

bioRxiv : the preprint server for biology·2025
Same author

MHC heterozygosity limits T cell receptor variability in CD4 T cells.

Science immunology·2024
Same author

Unraveling the Phenotypic States of Human innate-like T Cells: Comparative Insights with Conventional T Cells and Mouse Models.

bioRxiv : the preprint server for biology·2023
Same author

Single cell analysis of host response to helminth infection reveals the clonal breadth, heterogeneity, and tissue-specific programming of the responding CD4+ T cell repertoire.

PLoS pathogens·2021
Same author

Thymic iNKT single cell analyses unmask the common developmental program of mouse innate T cells.

Nature communications·2020
Same journal

Retraction: In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation.

The Journal of experimental medicine·2026
Same journal

Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical models.

The Journal of experimental medicine·2026
Same journal

Flawed translation triggers oncogenic B-T cell communication.

The Journal of experimental medicine·2026
Same journal

Correction: LCK'ed in: Inborn errors of immunity in LCK reveal how TCR signaling is calibrated.

The Journal of experimental medicine·2026
Same journal

Mechanobiology of inflammation: Pulling the strings of innate immunity.

The Journal of experimental medicine·2026
Same journal

Bile acid retention in efferocytic macrophages shapes their inflammatory status during cholangitis.

The Journal of experimental medicine·2026
See all related articles

Related Experiment Video

Updated: Nov 5, 2025

Rapid Quantification of Mitogen-induced Blastogenesis in T Lymphocytes for Identifying Immunomodulatory Drugs
08:13

Rapid Quantification of Mitogen-induced Blastogenesis in T Lymphocytes for Identifying Immunomodulatory Drugs

Published on: December 27, 2016

19.1K

CD1a autoreactivity: When size does matter.

Laurent Gapin1,2

  • 1Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO.

The Journal of Experimental Medicine
|May 20, 2021
PubMed
Summary
This summary is machine-generated.

CD1a-autoreactive T cells in humans are regulated by specific lipid interactions. CD1a molecules capture lipids, preventing autoreactive T cell antigen receptors from binding, offering new therapeutic targets.

More Related Videos

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

9.2K
Fabrication of Anisotropic Polymeric Artificial Antigen Presenting Cells for CD8+ T Cell Activation
10:16

Fabrication of Anisotropic Polymeric Artificial Antigen Presenting Cells for CD8+ T Cell Activation

Published on: October 12, 2018

8.2K

Related Experiment Videos

Last Updated: Nov 5, 2025

Rapid Quantification of Mitogen-induced Blastogenesis in T Lymphocytes for Identifying Immunomodulatory Drugs
08:13

Rapid Quantification of Mitogen-induced Blastogenesis in T Lymphocytes for Identifying Immunomodulatory Drugs

Published on: December 27, 2016

19.1K
Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

9.2K
Fabrication of Anisotropic Polymeric Artificial Antigen Presenting Cells for CD8+ T Cell Activation
10:16

Fabrication of Anisotropic Polymeric Artificial Antigen Presenting Cells for CD8+ T Cell Activation

Published on: October 12, 2018

8.2K

Area of Science:

  • Immunology
  • Cell Biology
  • Biochemistry

Background:

  • CD1a-autoreactive T cells are abundant in human circulation and skin.
  • The regulatory mechanisms of CD1a autoreactivity are not fully understood.

Purpose of the Study:

  • To investigate how CD1a molecules interact with cellular lipids and influence autoreactive T cell responses.

Main Methods:

  • Analysis of CD1a molecule interactions with various lipid classes.
  • Assessment of the impact of these interactions on autoreactive T cell antigen receptor binding.

Main Results:

  • CD1a molecules selectively capture specific lipid classes.
  • This lipid capture mechanism interferes with autoreactive T cell antigen receptor binding to CD1a.

Conclusions:

  • CD1a autoreactivity is regulated through selective lipid binding by CD1a molecules.
  • These findings suggest novel therapeutic strategies for modulating CD1a autoreactive T cell responses.